Dolby Laboratories (DLB) Receivables - Other (2019 - 2026)

Dolby Laboratories' Receivables - Other history runs 8 years deep, the most recent figure standing at $172.8 million for Q1 2026.

• Quarterly Receivables - Other rose 16.6% year-over-year to $172.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $172.8 million (up 16.6% YoY) and the FY2025 annual result came in at $180.8 million, down 8.44% from the prior year.
• Receivables - Other was $172.8 million for Q1 2026 at Dolby Laboratories, down from $178.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $197.5 million in Q3 2024 and bottomed at $104.2 million in Q2 2022.
• A 5-year average of $150.5 million and a median of $148.2 million in 2025 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2024 — Receivables - Other soared 31.68% — and 2025, when it declined 12.14%.
• Dolby Laboratories' Receivables - Other stood at $111.9 million in 2022, then advanced by 18.77% to $132.9 million in 2023, then soared by 31.68% to $175.0 million in 2024, then climbed by 1.71% to $178.0 million in 2025, then decreased by 2.92% to $172.8 million in 2026.
• Business Quant data shows DLB's Receivables - Other at $172.8 million in Q1 2026, $178.0 million in Q4 2025, and $173.5 million in Q3 2025.